Hans‐Peter Stoll

3.2k total citations
42 papers, 1.2k citations indexed

About

Hans‐Peter Stoll is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans‐Peter Stoll has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 24 papers in Cardiology and Cardiovascular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans‐Peter Stoll's work include Coronary Interventions and Diagnostics (30 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Cardiac Valve Diseases and Treatments (9 papers). Hans‐Peter Stoll is often cited by papers focused on Coronary Interventions and Diagnostics (30 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Cardiac Valve Diseases and Treatments (9 papers). Hans‐Peter Stoll collaborates with scholars based in Germany, France and United States. Hans‐Peter Stoll's co-authors include Philip Urban, Giulio Guagliumi, Patrick W. Serruys, William Wijns, Joachim Schöfer, Chaim Lotan, Anthony Gershlick, Ashok Seth, J. Eduardo Sousa and Philippe Guyon and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Hans‐Peter Stoll

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Peter Stoll Germany 17 1.0k 665 480 285 57 42 1.2k
Jun‐ichi Kotani Japan 18 1.5k 1.4× 1.1k 1.7× 584 1.2× 688 2.4× 60 1.1× 46 1.7k
Richard E. Kuntz United States 18 1.1k 1.0× 719 1.1× 391 0.8× 584 2.0× 36 0.6× 21 1.2k
K. Gert van Houwelingen Netherlands 18 1.1k 1.0× 858 1.3× 362 0.8× 355 1.2× 18 0.3× 57 1.2k
Martin G. Stoel Netherlands 22 1.5k 1.4× 1.4k 2.1× 400 0.8× 711 2.5× 34 0.6× 77 1.9k
Jeffrey J. Popma United States 14 1.1k 1.0× 760 1.1× 357 0.7× 667 2.3× 47 0.8× 25 1.2k
Vasile Sirbu Italy 19 1.2k 1.2× 925 1.4× 458 1.0× 518 1.8× 73 1.3× 43 1.5k
Lowell F. Satler United States 17 1.1k 1.0× 648 1.0× 388 0.8× 617 2.2× 24 0.4× 24 1.2k
Simon Eccleshall United Kingdom 14 623 0.6× 530 0.8× 282 0.6× 265 0.9× 65 1.1× 53 810
Javier Zueco Spain 19 804 0.8× 718 1.1× 336 0.7× 379 1.3× 43 0.8× 70 1.1k
Thierry Corcos France 19 985 0.9× 850 1.3× 419 0.9× 497 1.7× 40 0.7× 56 1.3k

Countries citing papers authored by Hans‐Peter Stoll

Since Specialization
Citations

This map shows the geographic impact of Hans‐Peter Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Peter Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Peter Stoll more than expected).

Fields of papers citing papers by Hans‐Peter Stoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Peter Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Peter Stoll. The network helps show where Hans‐Peter Stoll may publish in the future.

Co-authorship network of co-authors of Hans‐Peter Stoll

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Peter Stoll. A scholar is included among the top collaborators of Hans‐Peter Stoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Peter Stoll. Hans‐Peter Stoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marquis‐Gravel, Guillaume, Philip Urban, Samuel Copt, et al.. (2021). Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients. EuroIntervention. 17(3). 240–247. 4 indexed citations
2.
Sabaté, Manel, Lisette Okkels Jensen, Hans–Henrik Tilsted, et al.. (2021). Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial. EuroIntervention. 17(3). 233–239. 4 indexed citations
3.
Menown, Ian, Mamas A. Mamas, James Cotton, et al.. (2020). First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry. IJC Heart & Vasculature. 26. 100472–100472. 14 indexed citations
4.
Richardt, Gert, Mohammad Abdelghani, Abdelhakim Allali, et al.. (2020). Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial. Clinical Research in Cardiology. 110(2). 162–171. 3 indexed citations
5.
Díaz, Víctor Alfonso Jiménez, Thomas Hovasse, Andrés Íñiguez, et al.. (2019). Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial. Revista Española de Cardiología (English Edition). 73(7). 536–545. 1 indexed citations
6.
Lipiecki, Janusz, Philippe Brunel, Marie‐Claude Morice, et al.. (2018). Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial. EuroIntervention. 14(4). e418–e425. 19 indexed citations
7.
Lee, Jinhyun, Fahim Haider Jafary, Hee Hwa Ho, et al.. (2018). Polymer-free biolimus-A9-coated stent for primary percutaneous coronary intervention. Herz. 44(8). 750–755.
8.
9.
Waksman, Ron, Ameer Kabour, Louis Cannon, et al.. (2017). Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial. Cardiovascular revascularization medicine. 18(7). 475–481. 4 indexed citations
10.
Gray, William A., Andrew J. Feiring, Bruce H. Gray, et al.. (2014). S.M.A.R.T. Self-Expanding Nitinol Stent for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (STROLL): 1-Year Outcomes. Journal of Vascular and Interventional Radiology. 26(1). 21–28. 46 indexed citations
11.
12.
Cuculi, Florim, Adrian Banning, Alexandre Abizaid, et al.. (2011). Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry. EuroIntervention. 7(8). 962–968. 4 indexed citations
13.
Urban, Philip, Alexandre Abizaid, Adrian Banning, et al.. (2010). STENT THROMBOSIS, BLEEDING, AND ANTIPLATELET THERAPY IN THE E-SELECT REGISTRY: ONEYEAR FOLLOW-UP OF 15000 PATIENTS TREATED WITH THE SIROLIMUS-ELUTING CYPHER-SELECT STENT PLUS. Journal of the American College of Cardiology. 55(10). A125.E1166–A125.E1166. 1 indexed citations
14.
15.
16.
Baumgart, Dietrich, Volker Klauß, Frank M. Baer, et al.. (2007). One-Year Results of the SCORPIUS Study. Journal of the American College of Cardiology. 50(17). 1627–1634. 63 indexed citations
17.
18.
Krause, Korff, Kai Jaquet, Stephan Geidel, et al.. (2006). Percutaneous Endocardial Injection of Erythropoietin: Assessment of Cardioprotection by Electromechanical Mapping. European Journal of Heart Failure. 8(5). 443–450. 20 indexed citations
19.
Scheller, Bruno, Ulrich Speck, Alexander Schmitt, et al.. (2002). Acute Cardiac Tolerance of Current Contrast Media and the New Taxane Protaxel Using Iopromide as Carrier During Porcine Coronary Angiography and Stenting. Investigative Radiology. 37(1). 29–34. 16 indexed citations
20.
Stoll, Hans‐Peter, William H. Bay, W Vogel, et al.. (1994). Myocardial perfusion measured by dual-isotope acquisition of81rubidium/81mkrypton: an experimental verification of the method. Basic Research in Cardiology. 89(4). 354–365. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun‐ichi Kotani Breakdown of academic impact, for papers by Richard E. Kuntz Breakdown of academic impact, for papers by K. Gert van Houwelingen Breakdown of academic impact, for papers by Martin G. Stoel Breakdown of academic impact, for papers by Jeffrey J. Popma Breakdown of academic impact, for papers by Vasile Sirbu Breakdown of academic impact, for papers by Lowell F. Satler Breakdown of academic impact, for papers by Simon Eccleshall Breakdown of academic impact, for papers by Javier Zueco Breakdown of academic impact, for papers by Thierry Corcos
Rankless by CCL
2026